/Investor DB

National Institutes of Health (NIH) — Full Portfolio

2,639 tracked investments · page 14 of 14 · listed companies and verified rows first

Xoran Technologies LLCxorantech.cominMay 2016 · $12.2M

Xoran develops point-of-care CT imaging systems and related software for hospitals, clinics, and veterinary practices.

AI & Machine LearningHardwareHealthtechMedical DevicesAnn Arbor, US

XOSOMIX LLCxosomix.comSep 2022 · $318.9K

Xosomix develops exosome-based therapeutics aimed at treating brain and mental health disorders by using exosomes to target and improve the delivery and efficacy of drugs.

BiotechDeep TechDigital Health

XPLOSAFE LLCxplosafe.comin𝕏Mar 2017 · $150K

XploSafe provides real-time detection kits for identifying explosive compounds on-site, serving bomb squads and hazmat teams.

Deep TechDefense TechHardwareIoTNew MaterialsStillwater, US

Allen W. Apblett(President and Co-Founder)ShoaibNick Materer

XPOSE THERAPEUTICS, INCxposetx.cominAug 2020 · $297.7K

XPose Therapeutics is a drug discovery company using structure-based approaches to identify small molecule and biotherapeutic candidates across oncology, immunology, and other therapeutic areas.

AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US

Debanu Das(Co-Founder & CEO)Ashley Deacon(Co-Founder & VP Structural Biology)Matthew Duncton(Co-Founder & VP Medicinal Chemistry)Millie Georgiadis(Co-Founder)

XR NAVIGATION INCxrnavigation.ioJun 2023 · $275.8K
Xtem Pharmaceuticals Incxtempharma.comSep 2019 · $150K
XyloCor Therapeuticsxylocor.comJun 2023 · $300K

XyloCor Therapeutics develops gene therapies for advanced coronary artery disease and cardiac damage.

BiotechHealthtechMedical DevicesMalvern, US

Ronald Crystal(Founder and Advisor (Board Observer))Todd Rosengart(Founder; Board Observer)John Tucker(President and CEO)Albert Gianchetti(Executive Officer, Director)

BoardGlenn Batchelder(Director)inJames Cohen(Director)

Co-investorsLumira VenturesFountain Healthcare PartnersJeito CapitalLongwood FundSofinnova Ventures

Xylyx Bioxylyxbio.cominSep 2018 · $2.9M

XYLYX develops transplantation technologies using regenerative medicine, bioengineering, and translational science to expand access to organ transplantation.

BiotechHealthtechMedical DevicesNew York, US

John O'Neill(Chief Scientific Officer, Co-Founder, Board Director)in

Co-investorsBoston Harbor Angels

Yali Bioyalibio.cominSep 2023 · $370.6K

Yali develops fermentation technology to produce sustainable fats and lipids for alternative dairy products like ice cream, butter, and milk, using fewer inputs than conventional sources.

BiotechCleantechClimate TechFoodTech

Co-investorsFirst In VenturesFTW VenturesS2G InvestmentsCRCM VenturesThird Kind Venture Capital

YASO THERAPEUTICS INCORPORATEDyasotherapeutics.comMay 2017 · $6.8M

Yasa Therapeutics develops PPCM, a nanoscale polymer technology platform designed for contraception and anti-infective applications including viral and bacterial prevention.

BiotechFemTechHealthtechMedical Devices

Mary Weitzel(Co-Founder, CEO, President)Barbara North(Co-founder, Chief Medical Officer)Michael Oldham(Co-Founder, Regulatory Advisor, Pre-clinical development expert)

YELLOWSTONE SCIENTIFIC INSTRUMENTSyellowstonescientific.comSep 2015 · $2.1M
YENOS ANALYTICAL LLCyenosanalytical.comApr 2018 · $906.8K

Yenos Analytical develops microRNA-based liquid biopsy tests for early detection of multiple cancer types using urine samples.

BiotechDigital HealthHealthtechMedical DevicesEl Dorado Hills, US

Distinguished retired Professor from the University of California at Santa Cruz

Young Biopharma, LLCyoungbiopharma.comSep 2019 · $225K

Young BioPharma develops non-opioid pain and cancer therapies using natural product-based drug discovery.

BiotechHealthtechLowell, US

Young Shen(Founder, CEO)John Liu(Co-Founder, VP)

YOUNG THERAPEUTICS, LLCyoungtherapeutics.comJul 2019 · $911.3K

Young Therapeutics develops biotechnological therapeutics to mitigate ischemia reperfusion injury and improve cardiac and renal outcomes in critical medical situations.

BiotechMedical Devices

Z BIOTECH, LLCzbiotech.comAug 2017 · $4.4M

ZBiotech develops glycan microarray products and analysis services for research and diagnostics.

BiotechDeep TechHealthtechMedical Devices

Dr. Jian Zhang(Founder)Dr. Xi Chen

Z-Quick, LLCzquickdx.comMar 2018 · $599.8K
ZabBio, Inc.zabbio.comApr 2020 · $1.6M

ZabBio is developing contraceptive products.

BiotechFemTechHealthtech

ZAIPUT FLOW TECHNOLOGIES LLCzaiput.comin𝕏May 2021 · $1.7M

Zaiput Flow Technologies, an MIT spin-out, makes liquid-liquid and liquid-gas separators, back pressure regulators, and multi-stage extraction platforms for continuous flow chemistry.

Advanced ManufacturingDeep TechEnterprise SoftwareHardware

Zalgen Labszalgenlabs.comFeb 2015 · $2.8M
ZANSORS LLCzansors.comSep 2015 · $2.8M

Zansors develops sensor devices and mobile applications to monitor health biomarkers like heart rate and breathing patterns, enabling patients to detect early warning signs of conditions such as heart disease and sleep disorders.

Digital HealthHealthtechIoTMedical Devices

ZATA PHARMACEUTICALS, INC.www,zatapharmaceuticals.comSep 2015 · $6.2M
ZBeatszbeats.coSep 2022 · $314.6K

ZBeats is a cardiac technology company offering FDA-cleared electrocardiographic analysis software that transforms ECG signals into structured clinical intelligence for cardiology workflows.

AI & Machine LearningHealthtechMedical Devices

Co-investorsCamellia Venture Capital

Zebra Analytixzebraanalytix.comMay 2019 · $705.7K

Fayetteville, US

Michael Artinger(Executive Officer, Director)Bernie Prusaczyk(Executive Officer)Masoud Agah(Director)

BoardRobert Calvin Goforth(Director)

Zebra Biologicszebrabiologics.comSep 2019 · $823.5K

BiotechConcord, US

Ronald M. Lindsay(Executive Officer, Director)inRichard A. Lerner(Director)

BoardPhillip Frost(Director)

Zenalux Biomedical, Inc.zenalux.comSep 2014 · $3.1M
Zenflowzenflow.comin𝕏Sep 2017 · $2.5M

Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.

HealthtechMedical DevicesSan Francisco, US

Shreya Mehta(CTO)inNick Damiano(CEO)inJohn Beck(Executive Officer)in

BoardBryan Kim(Director)Robert Weisskoff(Director)inBlayne Roeder(Director)

Co-investorsAstiaCloudStone CapitalDorm RoomF-Prime CapitalShangBay Capital LLCY Combinator+16 more

Zenobia Therapeutics, Inc.zenobiatherapeutics.comJun 2016 · $1.2M
Zenopharm, LLCzenopharm.comApr 2017 · $2.3M
Zetagenzetagen.comSep 2018 · $2.8M

Zetagen is a biotechnology company focused on bone-related disease, developing small-molecule therapeutics and approaches targeting bone tumor progression, stem cell activity to promote bone formation, and cancers such as Ewing's sarcoma.

BiotechHealthtechMedical DevicesSyracuse, US

Joe C Loy(Executive Officer, Director)Peter B. Finn(Executive Officer)Nikhil Thakur, MD(Executive Officer, Director)David Tischler(Executive Officer, Director)

BoardRichard Warburg(Director)Ashok Kaveeshwar(Director)

Co-investorsJStar Capital Investments

Zeteo Techzeteotech.comMay 2023 · $967.5K

Zeteo Tech develops mass spectrometry and detection technologies for biomedical, defense, and security applications, including bioaerosol detection and breath analysis.

BiotechDeep TechDefense TechMedical DevicesSykesville, US

Charles J. Call(Executive Officer, Director)inWayne Bryden(President and CEO)inTom McCreery(VP, Innovation / Chief Innovation Officer)inMike McLoughlin(VP, Research / Chief Technology Officer)Susan Furney(Chief Operating Officer)Jerry Carlisle(Chief Financial Officer)

Co-investorsAnzu PartnersCottonwood Technology Fund

ZITEO, INC.ziteoinc.comSep 2016 · $224.9K

Ziteo Medical is developing a handheld, miniaturized intraoperative molecular imaging device that combines molecular imaging, computer vision, and augmented reality to help surgeons locate and remove cancerous tissue.

AI & Machine LearningHealthtechMedical DevicesBerkeley, US

ZoneOne Pharmazoneonepharma.com𝕏Apr 2015 · $2.4M

ZoneOne Pharma develops liposomal medicines for chronic disorders, leveraging proprietary delivery technologies to improve dosing and patient compliance compared to existing therapies.

BiotechHealthtechMedical Devices

Francis C. Szoka(Co-Founder, Chairman of the Board)Charles O. Noble(Founding Scientist, President)

ZRT LABORATORY, LLCzrtlab.cominAug 2019 · $201.4K

ZRT Laboratory provides at-home hormone and wellness testing using saliva and dried blood spot methods for individuals, healthcare providers, and research teams.

Digital HealthHealthtechWellness & Fitness

ZSX Medicalzipstitch.comSep 2021 · $1.7M

BiotechPhiladelphia, US

Daniel Mazzucco(Executive Officer, Director)Rugart Eric(Executive Officer, Director)

BoardLouis Berardi(Director)

Co-investorsBen Franklin Technology PartnersBroad Street AngelsRowan Innovation Venture Fund

Zylo Therapeuticszylotherapeutics.comSep 2019 · $2.9M

Zylö Therapeutics develops therapeutic delivery technology, focusing on product development in the biotech and drug-delivery space.

BiotechHealthtechGreenville, US

Scott R. Pancoast(CEO & Founder)inCharles E. Hinkle(Chief Financial Officer)inAndrew Draganski(Vice President, Product Development)Thomas Patrick Murray(Executive Officer)Lance Michael White(Director)Gary J Atkinson(Director)

Co-investorsAEON FoundryArieal Southeast Angel PartnersBoston Harbor AngelsCowtown AngelsHBS Angels of Boston

ZYMERON CORPORATIONzymeron.comin𝕏

Zymeron is a biotechnology company discovering and developing drugs for myeloprotection, cardioprotection, and neuroprotection focused on maintaining circulatory system health.

BiotechDeep TechDigital HealthHealthtechMedical DevicesResearch Triangle Park, US

ZYMO RESEARCH CORP.zymoresearch.comin𝕏May 2017 · $2.1M

Zymo Research develops biomedical tools and services for researchers in epigenetics, microbiomics, and next-generation sequencing.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechMedical DevicesIrvine, US

Larry Jia(Founder/CEO)

ZYMTRONIX CATALYTIC SYSTEMS, INC.zymtronix.comin𝕏Jan 2019 · $3.3M

Zymtronix develops cell-free, multi-enzyme biocatalysis systems to manufacture high-value industrial products without traditional fermentation.

AgTechBiotechNew Materials

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ZIVA CORPORATION

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.